Heart failure risk reduction: hydrophilic or lipophilic statins?

S. K. Kunutsor; J. A. Laukkanen

doi:10.1159/000506151

Heart failure risk reduction: hydrophilic or lipophilic statins?

S. K. Kunutsor
, J. A. Laukkanen

Research output: Contribution to journal › Editorial (Academic Journal) › peer-review

7 Citations (Scopus)

119 Downloads (Pure)

Abstract

[No abstract]

Original language	English
Number of pages	3
Journal	Cardiology (Switzerland)
Early online date	19 Feb 2020
DOIs	https://doi.org/10.1159/000506151
Publication status	E-pub ahead of print - 19 Feb 2020

Access to Document

10.1159/000506151

Full-text PDF (author’s accepted manuscript)
This is the author accepted manuscript (AAM). The final published version (version of record) is available online via Karger Publishers at https://www.karger.com/Article/FullText/506151 . Please refer to any applicable terms of use of the publisher.
Accepted author manuscript, 105 KB

Handle.net

Persistent link

Cite this

@article{91315d4e933445f1866d62ac23c633b6,

title = "Heart failure risk reduction: hydrophilic or lipophilic statins?",

abstract = "[No abstract]",

author = "Kunutsor, \{S. K.\} and Laukkanen, \{J. A.\}",

year = "2020",

month = feb,

day = "19",

doi = "10.1159/000506151",

language = "English",

journal = "Cardiology (Switzerland)",

issn = "0008-6312",

publisher = "Karger Publishers",

}

TY - JOUR

T1 - Heart failure risk reduction

T2 - hydrophilic or lipophilic statins?

AU - Kunutsor, S. K.

AU - Laukkanen, J. A.

PY - 2020/2/19

Y1 - 2020/2/19

N2 - [No abstract]

AB - [No abstract]

U2 - 10.1159/000506151

DO - 10.1159/000506151

M3 - Editorial (Academic Journal)

C2 - 32074601

SN - 0008-6312

JO - Cardiology (Switzerland)

JF - Cardiology (Switzerland)

ER -

Heart failure risk reduction: hydrophilic or lipophilic statins?

Abstract

Access to Document

Handle.net

Fingerprint

Cite this